BRIDGEWAY CAPITAL MANAGEMENT, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,734,901
-43.5%
633,079
-13.8%
0.07%
-43.1%
Q2 2023$4,837,554
+3.5%
734,075
+6.6%
0.12%
-6.5%
Q1 2023$4,673,808
+94.2%
688,337
+111.4%
0.12%
+100.0%
Q4 2022$2,406,184
-4.3%
325,600
+103.1%
0.06%
+31.9%
Q4 2021$2,515,000
+2.9%
160,300
+12.4%
0.05%0.0%
Q3 2021$2,444,000
-20.3%
142,6000.0%0.05%
-14.5%
Q2 2021$3,067,000
+427.0%
142,600
+307.4%
0.06%
+511.1%
Q3 2016$582,000
+48.5%
35,0000.0%0.01%
+50.0%
Q2 2016$392,000
+33.8%
35,0000.0%0.01%
+20.0%
Q1 2016$293,000
-46.9%
35,000
-41.0%
0.01%
-50.0%
Q4 2015$552,000
-17.5%
59,3000.0%0.01%
-28.6%
Q3 2015$669,000
-11.2%
59,3000.0%0.01%
-6.7%
Q2 2015$753,000
+2.2%
59,300
-25.2%
0.02%0.0%
Q1 2015$737,000
-35.7%
79,300
-0.9%
0.02%
-42.3%
Q4 2014$1,146,000
+38.1%
80,0000.0%0.03%
+23.8%
Q3 2014$830,000
-35.9%
80,0000.0%0.02%
-38.2%
Q2 2014$1,294,000
-62.9%
80,000
-62.8%
0.03%
-66.0%
Q1 2014$3,490,000
+13.3%
214,792
-13.4%
0.10%
+6.4%
Q4 2013$3,079,000
+13.3%
248,1000.0%0.09%
+1.1%
Q3 2013$2,717,000
+35.0%
248,100
-0.4%
0.09%
+16.2%
Q2 2013$2,013,000249,1000.08%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Signpost Capital Advisors, LP 1,688,952$27,327,00010.37%
Palo Alto Investors LP 3,240,424$52,430,0003.90%
Parametrica Management Ltd 12,509$202,0001.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,740,400$28,160,0001.08%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 557,100$9,014,0001.07%
Westend Capital Management, LLC 64,086$841,0001.00%
WALL STREET ASSOCIATES 702,700$11,370,0000.98%
Baker Brothers Advisors 4,372,153$70,741,0000.87%
Iguana Healthcare Management, LLC 100,000$1,618,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,085,301$17,560,0000.71%
View complete list of VANDA PHARMACEUTICALS INC shareholders